Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Frank Brasch is active.

Publication


Featured researches published by Frank Brasch.


American Journal of Pathology | 2004

Pivotal Role of Cathepsin K in Lung Fibrosis

Frank Bühling; Christoph Röcken; Frank Brasch; Roland Hartig; Yoshiyuki Yasuda; Paul Saftig; Dieter Brömme; Tobias Welte

The paramount importance of the homeostasis of the extracellular matrix for pulmonary function is exemplified by two opposing extremes: emphysema and pulmonary fibrosis. This study examined the putative role of cathepsin K (catK) in the pathology of lung fibrosis in mice and its relevance to the human disease activity. We compared the induction of lung fibrosis by administration of bleomycin. CTSK(-/-) mice deposited significantly more extracellular matrix than control mice. Primary lung fibroblasts derived from CTSK(-/-) mice showed a decreased collagenolytic activity indicating the role of catK in collagen degradation. Interestingly, CTSK(+/+) control mice revealed an increased expression of catK in fibrotic lung regions suggesting a protective role of catK to counter the excessive deposition of collagen matrix in the diseased lung. Similarly, in lung specimens obtained from patients with lung fibrosis fibroblasts expressed larger amounts of catK than those obtained from normal lungs. Activation of human pulmonary fibroblasts in primary cell cultures led to an increased activity of catK through enhanced gene transcription and protein expression and to increased intracellular collagenolytic activity. We believe that this is the first study to show that catK plays a pivotal role in lung matrix homeostasis under physiological and pathological conditions.


Pediatric Research | 2005

Nonspecific Interstitial Pneumonia, Alveolar Proteinosis, and Abnormal Proprotein Trafficking Resulting from a Spontaneous Mutation in the Surfactant Protein C Gene

Paul Stevens; Andrea Pettenazzo; Frank Brasch; Surafel Mulugeta; Aldo Baritussio; Matthias Ochs; Lake Morrison; Scott J. Russo; Michael F. Beers

Human surfactant protein C (hSP-C1–197) is synthesized as a 197 amino acid proprotein and cleaved to a mature 3.7 kD form. Although interstitial lung disease in patients with mutations of the hSP-C gene is becoming increasingly recognized, the mechanisms linking molecular events with clinical pathogenesis are not fully defined. We describe a full-term infant with respiratory insufficiency associated with a spontaneous heterozygous mutation resulting in a substitution of lysine for glutamic acid at position 66 (= E66K) of the proximal hSP-C COOH flanking propeptide. Lung histology and biochemical studies of the index patient (hSP-CE66K) revealed nonspecific interstitial pneumonia, increased alveolar total phospholipid lacking phosphatidylglycerol, and increased surfactant protein A. Localization of proSP-C from lung sections prepared from this patient using immunofluorescence and immunogold electron microscopy revealed abnormal proSP-C staining in endosomal-like vesicles of type II cells distinct from SP-B. To evaluate the effect of the E66K substitution on intracellular trafficking of proSP-C, fusion proteins consisting of enhanced green fluorescent protein (EGFP) and hSP-C1–197 (wild type) or mutant hSP-CE66K were generated and transfected into A549 cells. EGFP/hSP-C1–197 was expressed within CD-63-positive, EEA-1-negative vesicles, whereas EGFP/hSP-CE66K localized to EEA-1 positive vesicles. The E66K substitution is representative of a new class of SP-C mutation associated with interstitial lung disease that is diverted from the normal biosynthetic pathway. We propose that, similar to other storage disorders, lung injury results from induction of a toxic gain of function induced by the mutant product that is subject to genetic modifiers and environmental influences.


Histochemistry and Cell Biology | 2005

Distribution of surfactant proteins in type II pneumocytes of newborn, 14-day old, and adult rats: an immunoelectron microscopic and stereological study

Andreas Schmiedl; Matthias Ochs; Christian Mühlfeld; Georg Johnen; Frank Brasch

Surfactant proteins (SP) have an important impact on the function of the pulmonary surfactant. In contrast to humans, rat lungs are immature at birth. Alveolarization starts on postnatal day 4. Little is known about the distribution of SP during postnatal alveolarization. By immunoelectron microscopy, we studied the distribution of SP-A, SP-D, SP-B, and precursors of SP-C in type II pneumocytes before, near the end and after alveolarization and in mature lungs. We determined the subcellular volume fractions and the relative labeling index to obtain information about preferential labeling of compartments and non-randomness of labeling. Independently of alveolarization, the overall cellular distribution of SP was non-random. A preferential labeling for SP-A and SP-D was found in small vesicles and multivesicular bodies (mvb). SP-B and precursors of SP-C were localized in mvb and lamellar bodies (lb). There are no postnatal changes in labeling for all three SP in these compartments. Labeling intensity for SP-B in lb increased in close correlation with a significant increase in the volume fractions of lb during alveolarization. Our results support the concept that postnatal alveolarization in rat lungs is associated with significant increases in the SP-B content in lb and volume fraction of lb in type II pneumocytes. The postnatal compartment-specific distribution of SP-A, precursors of SP-C and SP-D does not change.


European Journal of Gastroenterology & Hepatology | 2004

Collagenous colitis: implications for the role of vascular endothelial growth factor in repair mechanisms.

Thomas Griga; Andreas Tromm; Wolff Schmiegel; Okka Pfisterer; Klaus-M. Müller; Frank Brasch

Objectives Collagenous colitis is a chronic inflammatory bowel disease with a band-like subepithelial deposition of immature extracellular matrix. Because the extracellular matrix deposition is potentially reversible, an imbalance between fibrogenesis and fibrolysis with reduced matrix degradation has been suspected. Vascular endothelial growth factor plays a central role in extracellular matrix degradation. Therefore, we investigated the expression of vascular endothelial growth factor in the colonic mucosa of patients with collagenous colitis before and after long-term treatment with oral budesonide. Method A quantitative immunohistochemical method was used to measure the amount of immunoreactive vascular endothelial growth factor, tenascin and leucocyte common antigen within the epithelium and the lamina propria of colonic biopsies by area morphometry. Results Strong immunostaining for vascular endothelial growth factor within the epithelium and the lamina propria, and for tenascin, was seen in patients with collagenous colitis compared with normal controls. The enhanced immunostaining for vascular endothelial growth factor within the lamina propria was accompanied by the accumulation of leucocytes, detected by staining for leucocyte common antigen. After long-term treatment with oral budesonide, the amount of immunostaining for leucocyte-derived vascular endothelial growth factor within the lamina propria decreased significantly to normal levels. In contrast, staining for vascular endothelial growth factor within the epithelium remained significantly increased. Conclusions Our data suggest an important role of vascular endothelial growth factor in counteracting the local imbalance of fibrogenesis and fibrolysis, leading to an accumulation of immature subepithelial matrix in collagenous colitis.


American Journal of Respiratory and Critical Care Medicine | 1998

Hyperventilation Induces Release of Cytokines from Perfused Mouse Lung

Alexander von Bethmann; Frank Brasch; Rolf Nüsing; Kathrin Vogt; H.-D. Volk; Klaus-Michael Müller; Albrecht Wendel; Stefan Uhlig


American Journal of Respiratory and Critical Care Medicine | 2006

Alteration of the Pulmonary Surfactant System in Full-Term Infants with Hereditary ABCA3 Deficiency

Frank Brasch; Sven Schimanski; Christian Mühlfeld; Stefan Barlage; Thomas Langmann; Charalampos Aslanidis; Alfred Boettcher; Ashraf Dada; Horst Schroten; Eva Mildenberger; Eric Prueter; Manfred Ballmann; Matthias Ochs; Georg Johnen; Matthias Griese; Gerd Schmitz


Journal of Biological Chemistry | 2003

Involvement of napsin A in the C- and N-terminal processing of surfactant protein B in type-II pneumocytes of the human lung.

Frank Brasch; Matthias Ochs; Thilo Kähne; Susan H. Guttentag; Vesna Schauer-Vukasinovic; Matthew Derrick; Georg Johnen; Nadine Kapp; K.-M. Müller; Joachim Richter; Thomas Giller; Samuel Hawgood; Frank Bühling


American Journal of Respiratory Cell and Molecular Biology | 2002

Involvement of cathepsin H in the processing of the hydrophobic surfactant-associated protein C in type II pneumocytes.

Frank Brasch; Anja ten Brinke; Georg Johnen; Matthias Ochs; Nadine Kapp; Klaus M. Muller; Michael F. Beers; Heinz Fehrenbach; Joachim Richter; Joseph J. Batenburg; Frank Bühling


American Journal of Pathology | 1995

Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro.

S. Uhlig; Frank Brasch; L. Wollin; H. Fehrenbach; J. Richter; Albrecht Wendel


American Journal of Respiratory Cell and Molecular Biology | 2002

Intracellular and intraalveolar localization of surfactant protein A (SP-A) in the parenchymal region of the human lung

Matthias Ochs; Georg Johnen; K.-M. Müller; Thorsten Wahlers; Samuel Hawgood; Joachim Richter; Frank Brasch

Collaboration


Dive into the Frank Brasch's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Samuel Hawgood

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Frank Bühling

Otto-von-Guericke University Magdeburg

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge